The U.S. Supreme Court thwarted a bid to limit access to a commonly used abortion drug, effectively countering recent attempts to restrict the procedure. What Happened: The Supreme Court, on Thursday, dismissed a case brought forward by anti-abortion proponents against the U.S. Food and Drug Administration (FDA), Financial Times reported on Friday. The plaintiffs contended that the FDA had not adequately approved mifepristone, a drug involved in over half of U.S. abortions, and had not evaluated its safety for girls under 18. Conservative justice Brett Kavanaugh, the author of the unanimous de…